Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL) Meeting Abstract
| Authors: | Chapman, P. B.; Sznol, M.; Lao, C.; Gonzalez, R.; Daniels, G. A.; Thompson, J. A.; Kudchadkar, R. R.; Sharfman, W. H.; Atkins, M. B.; Pavlick, A. C.; Infante, J. R.; Kim, K.; Weber, J. S.; Patel, S. P.; Nair, S.; Cowey, C. L.; Lipson, E. J.; Lee, S.; Avila, A.; Hodi, F. S. |
| Abstract Title: | Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 490s |
| Language: | English |
| ACCESSION: | WOS:000404711507147 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9525 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9525 -- Source: Wos |
